Aziende Chimiche Riunite Angelini Francesco S.p.a
Clinical trials sponsored by Aziende Chimiche Riunite Angelini Francesco S.p.a, explained in plain language.
-
New drug study aims to tame uncontrolled seizures
Disease control OngoingThis study is observing how well the drug cenobamate works for adults with focal epilepsy whose seizures are not controlled by at least two other medications. It follows 936 patients in Italy for one year to see how much it reduces seizure frequency and to check for side effects.…
Sponsor: Aziende Chimiche Riunite Angelini Francesco S.p.A • Aim: Disease control
Last updated Apr 01, 2026 23:41 UTC
-
Doctors track new epilepsy Drug's Real-Life impact
Disease control OngoingThis study aims to see how well an add-on anti-seizure medication works for adults with focal epilepsy in real-world settings. It will follow 300 patients for 12 months to measure changes in seizure frequency, safety, and quality of life. The goal is to understand the drug's effe…
Sponsor: Aziende Chimiche Riunite Angelini Francesco S.p.A • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC